Amerigen Pharmaceuticals Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Jan 18, 2019
  • No warning letters matched by name
Inspections 2 0 OAI
Recalls 4 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Amerigen Pharmaceuticals Inc. has 4 FDA recalls, 2 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Amerigen Pharmaceuticals Inc." is on file.

What these totals cover: FDA records filed under the name "Amerigen Pharmaceuticals Inc." and its spelling variant "Amerigen Pharmaceuticals".

Latest recall
D-0516-2019 · Class III · Feb 19, 2019
Latest inspection
Jan 18, 2019 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls4Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections2Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Amerigen Pharmaceuticals Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Amerigen Pharmaceuticals Inc.: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
202300000
202200000
202100000
202000000
201910010
201800030
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Amerigen Pharmaceuticals Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Amerigen Pharmaceuticals Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

4 recall records from Oct 5, 2018 to Feb 19, 2019.

NumberClassProductDate
D-0516-2019Class IIITemozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle…Feb 19, 2019
D-0345-2019Class IIITemozolomide Capsules, 180 mg, packaged in a 14 count bottles, Rx only, Mfd, by: Stason…Dec 20, 2018
D-0344-2019Class IIITemozolomide Capsules, 20 mg, packaged in a a) 5-count (NDC 43975-253-05) and b) 14 count (NDC…Dec 20, 2018
D-0249-2019Class IIITemozolomide capsules, 20 mg, packaged in a) 5-count bottle(NCD 43975-253-05), b) 14-count bottle…Oct 5, 2018

Recent FDA inspections

2 inspections from Jul 27, 2017 to Jan 18, 2019.

DateSiteProductClassificationFEI
Jan 18, 2019Lyndhurst, NJDrugsNo Action Indicated (NAI)3008849302
Jul 27, 2017Lyndhurst, NJDrugsVoluntary Action Indicated (VAI)3008849302
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3008849302Lyndhurst, NJ2Jan 18, 2019

Amerigen Pharmaceuticals Inc. and the FDA: common questions

Has Amerigen Pharmaceuticals Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "Amerigen Pharmaceuticals Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Amerigen Pharmaceuticals Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Amerigen Pharmaceuticals Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Amerigen Pharmaceuticals Inc.?

The most recent FDA inspection on file ended Jan 18, 2019 at Lyndhurst, NJ and was classified NAI. FDA has 2 inspections of Amerigen Pharmaceuticals Inc. on file.

Has Amerigen Pharmaceuticals Inc. had an FDA recall?

Yes. Amerigen Pharmaceuticals Inc. has 4 FDA recalls on record. The most recent started Feb 19, 2019.

Need more than this page shows? Ask about Amerigen Pharmaceuticals Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.